Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dan H Barouch

Showing results (31-40 of 482) with videos related to

Pageof 49
Sort By:
Immunological Reviews|January 31, 2017
Systems serology for evaluation of HIV vaccine trialsMargaret E Ackerman, Dan H Barouch, Galit Alter
Journal of the International AIDS Society|May 17, 2024
The potential of broadly neutralizing antibodies for HIV preventionHuub C Gelderblom, Lawrence Corey, Dan H Barouch
Immunological Reviews|November 18, 2004
The role of cytokine DNAs as vaccine adjuvants for optimizing cellular immune responsesDan H Barouch, Norman L Letvin, Robert A Seder
Journal of Virology|July 13, 2012
Vaccination with adenovirus serotypes 35, 26, and 48 elicits higher levels of innate cytokine responses than adenovirus serotype 5 in rhesus monkeysJeffrey E Teigler, M Justin Iampietro, Dan H Barouch
Vaccine|September 6, 2024
Insights from an observational translational research program during the COVID-19 pandemic: Four years of experienceMarjorie Rowe, Ai-Ris Yonekura Collier, Dan H Barouch
Current Opinion in Immunology|June 9, 2016
New concepts in HIV-1 vaccine developmentKathryn E Stephenson, Helen T D'Couto, Dan H Barouch
Immunity|February 24, 2017
Prospects for a Zika Virus VaccineDan H Barouch, Stephen J Thomas, Nelson L Michael
Current Opinion in HIV and AIDS|August 9, 2013
Nonreplicating vectors in HIV vaccinesJennifer A Johnson, Dan H Barouch, Lindsay R Baden
Viral Immunology|July 29, 2004
Structural constraints on viral escape from HIV- and SIV-specific cytotoxic T-lymphocytesFred W Peyerl, Dan H Barouch, Norman L Letvin
Vaccine|August 7, 2004
Expression kinetics of the interleukin-2/immunoglobulin (IL-2/Ig) plasmid cytokine adjuvantDan H Barouch, Diana M Truitt, Norman L Letvin
Pageof 49

Showing results (31-40 of 482) with videos related to

Sort By:
Pageof 49
Immunological Reviews|January 31, 2017
Systems serology for evaluation of HIV vaccine trialsMargaret E Ackerman, Dan H Barouch, Galit Alter
Journal of the International AIDS Society|May 17, 2024
The potential of broadly neutralizing antibodies for HIV preventionHuub C Gelderblom, Lawrence Corey, Dan H Barouch
Immunological Reviews|November 18, 2004
The role of cytokine DNAs as vaccine adjuvants for optimizing cellular immune responsesDan H Barouch, Norman L Letvin, Robert A Seder
Journal of Virology|July 13, 2012
Vaccination with adenovirus serotypes 35, 26, and 48 elicits higher levels of innate cytokine responses than adenovirus serotype 5 in rhesus monkeysJeffrey E Teigler, M Justin Iampietro, Dan H Barouch
Vaccine|September 6, 2024
Insights from an observational translational research program during the COVID-19 pandemic: Four years of experienceMarjorie Rowe, Ai-Ris Yonekura Collier, Dan H Barouch
Current Opinion in Immunology|June 9, 2016
New concepts in HIV-1 vaccine developmentKathryn E Stephenson, Helen T D'Couto, Dan H Barouch
Immunity|February 24, 2017
Prospects for a Zika Virus VaccineDan H Barouch, Stephen J Thomas, Nelson L Michael
Current Opinion in HIV and AIDS|August 9, 2013
Nonreplicating vectors in HIV vaccinesJennifer A Johnson, Dan H Barouch, Lindsay R Baden
Viral Immunology|July 29, 2004
Structural constraints on viral escape from HIV- and SIV-specific cytotoxic T-lymphocytesFred W Peyerl, Dan H Barouch, Norman L Letvin
Vaccine|August 7, 2004
Expression kinetics of the interleukin-2/immunoglobulin (IL-2/Ig) plasmid cytokine adjuvantDan H Barouch, Diana M Truitt, Norman L Letvin
Pageof 49